{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T16:40:35Z","timestamp":1772124035229,"version":"3.50.1"},"publisher-location":"Cham","reference-count":81,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030304010","type":"print"},{"value":"9783030304027","type":"electronic"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1007\/978-3-030-30402-7_22","type":"book-chapter","created":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T08:04:26Z","timestamp":1580457866000},"page":"601-614","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Natural Products and Their Therapeutic Effect on Autism Spectrum Disorder"],"prefix":"10.1007","author":[{"given":"Satarupa","family":"Deb","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Banashree Chetia","family":"Phukan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ankumoni","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajib","family":"Paul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pallab","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thamilarasan","family":"Manivasagam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arokiasamy Justin","family":"Thenmozhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chidambaram Saravana","family":"Babu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Musthafa Mohamed","family":"Essa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anupom","family":"Borah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,2,1]]},"reference":[{"key":"22_CR1","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(13)61539-1","volume":"383","author":"M-C Lai","year":"2014","unstructured":"Lai, M.-C., Lombardo, M. V., & Baron-Cohen, S. (2014). Autism. Lancet, 383, 896\u2013910. https:\/\/doi.org\/10.1016\/S0140-6736(13)61539-1","journal-title":"Lancet"},{"key":"22_CR2","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/BF01537863","volume":"8","author":"M Rutter","year":"1978","unstructured":"Rutter, M. (1978). Diagnosis and definition of childhood autism. Journal of Autism and Childhood Schizophrenia, 8, 139\u2013161.","journal-title":"Journal of Autism and Childhood Schizophrenia"},{"key":"22_CR3","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/B978-0-444-52002-9.00023-1","volume":"106","author":"J McPartland","year":"2012","unstructured":"McPartland, J., & Volkmar, F. R. (2012). Autism and related disorders. Handbook of Clinical Neurology, 106, 407\u2013418. https:\/\/doi.org\/10.1016\/B978-0-444-52002-9.00023-1","journal-title":"Handbook of Clinical Neurology"},{"key":"22_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0199590","volume":"13","author":"M Adachi","year":"2018","unstructured":"Adachi, M., Takahashi, M., Takayanagi, N., Yoshida, S., Yasuda, S., Tanaka, M., et al. (2018). Adaptation of the Autism Spectrum Screening Questionnaire (ASSQ) to preschool children. PLoS One, 13, e0199590. https:\/\/doi.org\/10.1371\/journal.pone.0199590","journal-title":"PLoS One"},{"key":"22_CR5","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/aur.239","volume":"5","author":"M Elsabbagh","year":"2012","unstructured":"Elsabbagh, M., Divan, G., Koh, Y.-J., Kim, Y. S., Kauchali, S., Marc\u00edn, C., et al. (2012). Global prevalence of autism and other pervasive developmental disorders. Autism Research, 5, 160\u2013179. https:\/\/doi.org\/10.1002\/aur.239","journal-title":"Autism Research"},{"key":"22_CR6","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3109\/1547691X.2010.545086","volume":"8","author":"HV Ratajczak","year":"2011","unstructured":"Ratajczak, H. V. (2011). Theoretical aspects of autism: Causes\u2014A review. Journal of Immunotoxicology, 8, 68\u201379. https:\/\/doi.org\/10.3109\/1547691X.2010.545086","journal-title":"Journal of Immunotoxicology"},{"key":"22_CR7","doi-asserted-by":"crossref","first-page":"281","DOI":"10.31887\/DCNS.2012.14.3\/pchaste","volume":"14","author":"P Chaste","year":"2012","unstructured":"Chaste, P., & Leboyer, M. (2012). Autism risk factors: Genes, environment, and gene-environment interactions. Dialogues in Clinical Neuroscience, 14, 281\u2013292.","journal-title":"Dialogues in Clinical Neuroscience"},{"key":"22_CR8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jtemb.2016.06.002","volume":"37","author":"JK Kern","year":"2016","unstructured":"Kern, J. K., Geier, D. A., Sykes, L. K., Haley, B. E., & Geier, M. R. (2016). The relationship between mercury and autism: A comprehensive review and discussion. Journal of Trace Elements in Medicine and Biology, 37, 8\u201324. https:\/\/doi.org\/10.1016\/j.jtemb.2016.06.002","journal-title":"Journal of Trace Elements in Medicine and Biology"},{"key":"22_CR9","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1007\/s10803-014-2033-x","volume":"44","author":"Z Xiao","year":"2014","unstructured":"Xiao, Z., Qiu, T., Ke, X., Xiao, X., Xiao, T., Liang, F., et al. (2014). Autism spectrum disorder as early neurodevelopmental disorder: Evidence from the brain imaging abnormalities in 2\u20133 years old toddlers. Journal of Autism and Developmental Disorders, 44, 1633\u20131640. https:\/\/doi.org\/10.1007\/s10803-014-2033-x","journal-title":"Journal of Autism and Developmental Disorders"},{"key":"22_CR10","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1001\/journalofethics.2015.17.4.sect1-1504","volume":"17","author":"S Bent","year":"2015","unstructured":"Bent, S., & Hendren, R. L. (2015). Complementary and alternative treatments for autism Part 1: Evidence-supported treatments. AMA Journal of Ethics, 17, 369\u2013374. https:\/\/doi.org\/10.1001\/journalofethics.2015.17.4.sect1-1504","journal-title":"AMA Journal of Ethics"},{"key":"22_CR11","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1177\/0031512517743823","volume":"125","author":"CVA Toscano","year":"2018","unstructured":"Toscano, C. V. A., Carvalho, H. M., & Ferreira, J. P. (2018). Exercise effects for children with autism spectrum disorder: Metabolic health, autistic traits, and quality of life. Perceptual and Motor Skills, 125, 126\u2013146. https:\/\/doi.org\/10.1177\/0031512517743823","journal-title":"Perceptual and Motor Skills"},{"key":"22_CR12","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.pedhc.2016.12.001","volume":"31","author":"D Nath","year":"2017","unstructured":"Nath, D. (2017). Complementary and alternative medicine in the school-age child with autism. Journal of Pediatric Health Care, 31, 393\u2013397. https:\/\/doi.org\/10.1016\/j.pedhc.2016.12.001","journal-title":"Journal of Pediatric Health Care"},{"key":"22_CR13","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.pcl.2007.09.006","volume":"54","author":"W Weber","year":"2007","unstructured":"Weber, W., & Newmark, S. (2007). Complementary and alternative medical therapies for attention-deficit\/hyperactivity disorder and autism. Pediatric Clinics of North America, 54, 983\u20131006. https:\/\/doi.org\/10.1016\/j.pcl.2007.09.006","journal-title":"Pediatric Clinics of North America"},{"key":"22_CR14","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1007\/s10803-017-3117-1","volume":"47","author":"DMJ Veld de","year":"2017","unstructured":"de Veld, D. M. J., Howlin, P., Hoddenbach, E., Mulder, F., Wolf, I., Koot, H. M., et al. (2017). Moderating effects of parental characteristics on the effectiveness of a theory of mind training for children with autism: A randomized controlled trial. Journal of Autism and Developmental Disorders, 47, 1987\u20131997. https:\/\/doi.org\/10.1007\/s10803-017-3117-1","journal-title":"Journal of Autism and Developmental Disorders"},{"key":"22_CR15","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.bbr.2017.04.038","volume":"331","author":"K Yenkoyan","year":"2017","unstructured":"Yenkoyan, K., Grigoryan, A., Fereshetyan, K., & Yepremyan, D. (2017). Advances in understanding the pathophysiology of autism spectrum disorders. Behavioural Brain Research, 331, 92\u2013101. https:\/\/doi.org\/10.1016\/j.bbr.2017.04.038","journal-title":"Behavioural Brain Research"},{"key":"22_CR16","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1515\/revneuro-2014-0056","volume":"25","author":"S Bhat","year":"2014","unstructured":"Bhat, S., Acharya, U. R., Adeli, H., Bairy, G. M., & Adeli, A. (2014). Autism: Cause factors, early diagnosis and therapies. Reviews in the Neurosciences, 25, 841\u2013850. https:\/\/doi.org\/10.1515\/revneuro-2014-0056","journal-title":"Reviews in the Neurosciences"},{"key":"22_CR17","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/S0165-5728(98)00021-6","volume":"85","author":"S Gupta","year":"1998","unstructured":"Gupta, S., Aggarwal, S., Rashanravan, B., & Lee, T. (1998). Th1- and Th2-like cytokines in CD4+ and CD8+ T cells in autism. Journal of Neuroimmunology, 85, 106\u2013109. https:\/\/doi.org\/10.1016\/S0165-5728(98)00021-6","journal-title":"Journal of Neuroimmunology"},{"key":"22_CR18","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3389\/fpsyt.2014.00053","volume":"5","author":"S Tordjman","year":"2014","unstructured":"Tordjman, S., Somogyi, E., Coulon, N., Kermarrec, S., Cohen, D., Bronsard, G., et al. (2014). Gene \u00d7 Environment interactions in autism spectrum disorders: Role of epigenetic mechanisms. Frontiers in Psychiatry, 5, 53. https:\/\/doi.org\/10.3389\/fpsyt.2014.00053","journal-title":"Frontiers in Psychiatry"},{"key":"22_CR19","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1542\/peds.2010-1036","volume":"128","author":"H Gardener","year":"2011","unstructured":"Gardener, H., Spiegelman, D., & Buka, S. L. (2011). Perinatal and neonatal risk factors for autism: A comprehensive meta-analysis. Pediatrics, 128, 344\u2013355. https:\/\/doi.org\/10.1542\/peds.2010-1036","journal-title":"Pediatrics"},{"key":"22_CR20","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1111\/cch.12612","volume":"44","author":"V Chaidez","year":"2018","unstructured":"Chaidez, V., Fernandez y Garcia, E., Wang, L. W., Angkustsiri, K., Krakowiak, P., Hertz-Picciotto, I., et al. (2018). Comparison of maternal beliefs about causes of autism spectrum disorder and association with utilization of services and treatments. Child: Care, Health and Development, 44, 916\u2013925. https:\/\/doi.org\/10.1111\/cch.12612","journal-title":"Child: Care, Health and Development"},{"key":"22_CR21","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.bbr.2017.06.035","volume":"333","author":"H Yamaguchi","year":"2017","unstructured":"Yamaguchi, H., Hara, Y., Ago, Y., Takano, E., Hasebe, S., Nakazawa, T., et al. (2017). Environmental enrichment attenuates behavioral abnormalities in valproic acid-exposed autism model mice. Behavioural Brain Research, 333, 67\u201373. https:\/\/doi.org\/10.1016\/j.bbr.2017.06.035","journal-title":"Behavioural Brain Research"},{"key":"22_CR22","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1016\/j.neubiorev.2008.06.004","volume":"32","author":"D Kinney","year":"2008","unstructured":"Kinney, D., Munir, K., Crowley, D., & Miller, A. (2008). Prenatal stress and risk for autism. Neuroscience and Biobehavioral Reviews, 32, 1519\u20131532. https:\/\/doi.org\/10.1016\/j.neubiorev.2008.06.004","journal-title":"Neuroscience and Biobehavioral Reviews"},{"key":"22_CR23","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1093\/ije\/dyt282","volume":"43","author":"K Lyall","year":"2014","unstructured":"Lyall, K., Schmidt, R. J., & Hertz-Picciotto, I. (2014). Maternal lifestyle and environmental risk factors for autism spectrum disorders. International Journal of Epidemiology, 43, 443\u2013464. https:\/\/doi.org\/10.1093\/ije\/dyt282","journal-title":"International Journal of Epidemiology"},{"key":"22_CR24","doi-asserted-by":"publisher","first-page":"6","DOI":"10.4103\/0973-4651.200297","volume":"15","author":"S Zachariah","year":"2017","unstructured":"Zachariah, S., Oommen, S., & Koshy, B. (2017). Clinical features and diagnosis of autism spectrum disorder in children. Current Medical Issues, 15, 6. https:\/\/doi.org\/10.4103\/0973-4651.200297","journal-title":"Current Medical Issues"},{"key":"22_CR25","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1146\/annurev.clinpsy.2.022305.095210","volume":"2","author":"M Sigman","year":"2006","unstructured":"Sigman, M., Spence, S. J., & Wang, A. T. (2006). Autism from developmental and neuropsychological perspectives. Annual Review of Clinical Psychology, 2, 327\u2013355. https:\/\/doi.org\/10.1146\/annurev.clinpsy.2.022305.095210","journal-title":"Annual Review of Clinical Psychology"},{"key":"22_CR26","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1017\/S0954579408000527","volume":"20","author":"K O\u2019Hearn","year":"2008","unstructured":"O\u2019Hearn, K., Asato, M., Ordaz, S., & Luna, B. (2008). Neurodevelopment and executive function in autism. Development and Psychopathology, 20, 1103. https:\/\/doi.org\/10.1017\/S0954579408000527","journal-title":"Development and Psychopathology"},{"key":"22_CR27","doi-asserted-by":"publisher","first-page":"6392","DOI":"10.1523\/JNEUROSCI.1297-04.2004","volume":"24","author":"CM Schumann","year":"2004","unstructured":"Schumann, C. M., Hamstra, J., Goodlin-Jones, B. L., Lotspeich, L. J., Kwon, H., Buonocore, M. H., et al. (2004). The amygdala is enlarged in children but not adolescents with autism; the hippocampus is enlarged at all ages. The Journal of Neuroscience, 24, 6392\u20136401. https:\/\/doi.org\/10.1523\/JNEUROSCI.1297-04.2004","journal-title":"The Journal of Neuroscience"},{"key":"22_CR28","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s12311-012-0355-9","volume":"11","author":"SH Fatemi","year":"2012","unstructured":"Fatemi, S. H., Aldinger, K. A., Ashwood, P., Bauman, M. L., Blaha, C. D., Blatt, G. J., et al. (2012). Consensus paper: Pathological role of the cerebellum in autism. The Cerebellum, 11, 777\u2013807. https:\/\/doi.org\/10.1007\/s12311-012-0355-9","journal-title":"The Cerebellum"},{"key":"22_CR29","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.pcl.2011.10.010","volume":"59","author":"WG Silver","year":"2012","unstructured":"Silver, W. G., & Rapin, I. (2012). Neurobiological basis of autism. Pediatric Clinics of North America, 59, 45\u201361. https:\/\/doi.org\/10.1016\/j.pcl.2011.10.010","journal-title":"Pediatric Clinics of North America"},{"key":"22_CR30","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1542\/peds.2007-2362","volume":"120","author":"SM Myers","year":"2007","unstructured":"Myers, S. M., Johnson, C. P., & American Academy of Pediatrics Council on Children With Disabilities. (2007). Management of children with autism spectrum disorders. Pediatrics, 120, 1162\u20131182. https:\/\/doi.org\/10.1542\/peds.2007-2362","journal-title":"Pediatrics"},{"issue":"Suppl 2","key":"22_CR31","doi-asserted-by":"publisher","first-page":"S69","DOI":"10.1542\/peds.2012-0900D","volume":"130","author":"DL Coury","year":"2012","unstructured":"Coury, D. L., Anagnostou, E., Manning-Courtney, P., Reynolds, A., Cole, L., McCoy, R., et al. (2012). Use of psychotropic medication in children and adolescents with autism spectrum disorders. Pediatrics, 130(Suppl 2), S69\u2013S76. https:\/\/doi.org\/10.1542\/peds.2012-0900D","journal-title":"Pediatrics"},{"key":"22_CR32","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13229-018-0222-8","volume":"9","author":"M Benger","year":"2018","unstructured":"Benger, M., Kinali, M., & Mazarakis, N. D. (2018). Autism spectrum disorder: Prospects for treatment using gene therapy. Molecular Autism, 9, 39. https:\/\/doi.org\/10.1186\/s13229-018-0222-8","journal-title":"Molecular Autism"},{"key":"22_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/8614680","volume":"2017","author":"M Bang","year":"2017","unstructured":"Bang, M., Lee, S. H., Cho, S.-H., Yu, S.-A., Kim, K., Lu, H. Y., et al. (2017). Herbal medicine treatment for children with autism spectrum disorder: A systematic review. Evidence-Based Complementary and Alternative Medicine, 2017, 1\u201312. https:\/\/doi.org\/10.1155\/2017\/8614680","journal-title":"Evidence-Based Complementary and Alternative Medicine"},{"key":"22_CR34","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.devcel.2015.01.018","volume":"32","author":"AM Casano","year":"2015","unstructured":"Casano, A. M., & Peri, F. (2015). Microglia: Multitasking specialists of the brain. Developmental Cell, 32, 469\u2013477. https:\/\/doi.org\/10.1016\/j.devcel.2015.01.018","journal-title":"Developmental Cell"},{"key":"22_CR35","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1742-2094-1-14","volume":"1","author":"WJ Streit","year":"2004","unstructured":"Streit, W. J., Mrak, R. E., & Griffin, W. S. T. (2004). Microglia and neuroinflammation: A pathological perspective. Journal of Neuroinflammation, 1, 14. https:\/\/doi.org\/10.1186\/1742-2094-1-14","journal-title":"Journal of Neuroinflammation"},{"key":"22_CR36","doi-asserted-by":"publisher","first-page":"246","DOI":"10.9758\/cpn.2018.16.3.246","volume":"16","author":"JW Kim","year":"2018","unstructured":"Kim, J. W., Hong, J. Y., & Bae, S. M. (2018). Microglia and autism spectrum disorder: Overview of current evidence and novel immunomodulatory treatment options. Clinical Psychopharmacology and Neuroscience, 16, 246\u2013252. https:\/\/doi.org\/10.9758\/cpn.2018.16.3.246","journal-title":"Clinical Psychopharmacology and Neuroscience"},{"key":"22_CR37","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3389\/fpsyt.2015.00121","volume":"6","author":"C Gottfried","year":"2015","unstructured":"Gottfried, C., Bambini-Junior, V., Francis, F., Riesgo, R., & Savino, W. (2015). The impact of neuroimmune alterations in autism spectrum disorder. Frontiers in Psychiatry, 6, 121. https:\/\/doi.org\/10.3389\/fpsyt.2015.00121","journal-title":"Frontiers in Psychiatry"},{"key":"22_CR38","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1159\/000492225","volume":"25","author":"J Marchezan","year":"2018","unstructured":"Marchezan, J., Winkler Dos Santos, E. G. A., Deckmann, I., & Riesgo, R. D. S. (2018). Immunological dysfunction in autism spectrum disorder: A potential target for therapy. Neuroimmunomodulation, 25, 300\u2013319. https:\/\/doi.org\/10.1159\/000492225","journal-title":"Neuroimmunomodulation"},{"key":"22_CR39","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1002\/dvdy.24612","volume":"247","author":"CM Solek","year":"2018","unstructured":"Solek, C. M., Farooqi, N., Verly, M., Lim, T. K., & Ruthazer, E. S. (2018). Maternal immune activation in neurodevelopmental disorders. Developmental Dynamics, 247, 588\u2013619. https:\/\/doi.org\/10.1002\/dvdy.24612","journal-title":"Developmental Dynamics"},{"key":"22_CR40","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/J.NEULET.2017.06.004","volume":"653","author":"M Zuiki","year":"2017","unstructured":"Zuiki, M., Chiyonobu, T., Yoshida, M., Maeda, H., Yamashita, S., Kidowaki, S., et al. (2017). Luteolin attenuates interleukin-6-mediated astrogliosis in human iPSC-derived neural aggregates: A candidate preventive substance for maternal immune activation-induced abnormalities. Neuroscience Letters, 653, 296\u2013301. https:\/\/doi.org\/10.1016\/J.NEULET.2017.06.004","journal-title":"Neuroscience Letters"},{"key":"22_CR41","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/S0344-0338(85)80075-3","volume":"180","author":"F Gullotta","year":"1985","unstructured":"Gullotta, F., Schindler, F., Schmutzler, R., & Weeks-Seifert, A. (1985). GFAP in brain tumor diagnosis: Possibilities and limitations. Pathology, Research and Practice, 180, 54\u201360. https:\/\/doi.org\/10.1016\/S0344-0338(85)80075-3","journal-title":"Pathology, Research and Practice"},{"key":"22_CR42","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.2174\/15665240113139990076","volume":"13","author":"E Chen","year":"2013","unstructured":"Chen, E., Xu, D., Lan, X., Jia, B., Sun, L., Zheng, J. C., et al. (2013). A novel role of the STAT3 pathway in brain inflammation-induced human neural progenitor cell differentiation. Current Molecular Medicine, 13, 1474\u20131484.","journal-title":"Current Molecular Medicine"},{"key":"22_CR43","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.modgep.2007.06.002","volume":"7","author":"O Golonzhka","year":"2007","unstructured":"Golonzhka, O., Leid, M., Indra, G., & Indra, A. K. (2007). Expression of COUP-TF-interacting protein 2 (CTIP2) in mouse skin during development and in adulthood. Gene Expression Patterns, 7, 754\u2013760. https:\/\/doi.org\/10.1016\/j.modgep.2007.06.002","journal-title":"Gene Expression Patterns"},{"key":"22_CR44","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1101\/gr.203612.115","volume":"26","author":"JH Notwell","year":"2016","unstructured":"Notwell, J. H., Heavner, W. E., Darbandi, S. F., Katzman, S., McKenna, W. L., Ortiz-Londono, C. F., et al. (2016). TBR1 regulates autism risk genes in the developing neocortex. Genome Research, 26, 1013\u20131022. https:\/\/doi.org\/10.1101\/gr.203612.115","journal-title":"Genome Research"},{"key":"22_CR45","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/cns.12648","volume":"23","author":"B Bertolino","year":"2017","unstructured":"Bertolino, B., Crupi, R., Impellizzeri, D., Bruschetta, G., Cordaro, M., Siracusa, R., et al. (2017). Beneficial effects of co-ultramicronized palmitoylethanolamide\/luteolin in a mouse model of autism and in a case report of autism. CNS Neuroscience & Therapeutics, 23, 87\u201398. https:\/\/doi.org\/10.1111\/cns.12648","journal-title":"CNS Neuroscience & Therapeutics"},{"key":"22_CR46","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1177\/039463201202500201","volume":"25","author":"TC Theoharides","year":"2012","unstructured":"Theoharides, T. C., Asadi, S., & Panagiotidou, S. (2012). A case series of a luteolin formulation (NeuroProtek\u00ae) in children with autism spectrum disorders. International Journal of Immunopathology and Pharmacology, 25, 317\u2013323. https:\/\/doi.org\/10.1177\/039463201202500201","journal-title":"International Journal of Immunopathology and Pharmacology"},{"key":"22_CR47","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.neulet.2008.10.046","volume":"448","author":"H-Q Chen","year":"2008","unstructured":"Chen, H.-Q., Jin, Z.-Y., Wang, X.-J., Xu, X.-M., Deng, L., & Zhao, J.-W. (2008). Luteolin protects dopaminergic neurons from inflammation-induced injury through inhibition of microglial activation. Neuroscience Letters, 448, 175\u2013179. https:\/\/doi.org\/10.1016\/j.neulet.2008.10.046","journal-title":"Neuroscience Letters"},{"key":"22_CR48","doi-asserted-by":"publisher","first-page":"531518","DOI":"10.1155\/2015\/531518","volume":"2015","author":"N Xu","year":"2015","unstructured":"Xu, N., Li, X., & Zhong, Y. (2015). Inflammatory cytokines: Potential biomarkers of immunologic dysfunction in autism spectrum disorders. Mediators of Inflammation, 2015, 531518. https:\/\/doi.org\/10.1155\/2015\/531518","journal-title":"Mediators of Inflammation"},{"key":"22_CR49","doi-asserted-by":"publisher","first-page":"e647","DOI":"10.1038\/tp.2015.142","volume":"5","author":"I Tsilioni","year":"2015","unstructured":"Tsilioni, I., Taliou, A., Francis, K., & Theoharides, T. C. (2015). Children with autism spectrum disorders, who improved with a luteolin-containing dietary formulation, show reduced serum levels of TNF and IL-6. Translational Psychiatry, 5, e647\u2013e647. https:\/\/doi.org\/10.1038\/tp.2015.142","journal-title":"Translational Psychiatry"},{"key":"22_CR50","first-page":"955","volume":"27","author":"SK Kritas","year":"2013","unstructured":"Kritas, S. K., Saggini, A., Varvara, G., Murmura, G., Caraffa, A., Antinolfi, P., et al. (2013). Luteolin inhibits mast cell-mediated allergic inflammation. Journal of Biological Regulators and Homeostatic Agents, 27, 955\u2013959.","journal-title":"Journal of Biological Regulators and Homeostatic Agents"},{"key":"22_CR51","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3389\/fphys.2014.00150","volume":"5","author":"DA Rossignol","year":"2014","unstructured":"Rossignol, D. A., & Frye, R. E. (2014). Evidence linking oxidative stress, mitochondrial dysfunction, and inflammation in the brain of individuals with autism. Frontiers in Physiology, 5, 150. https:\/\/doi.org\/10.3389\/fphys.2014.00150","journal-title":"Frontiers in Physiology"},{"key":"22_CR52","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.pathophys.2006.05.007","volume":"13","author":"A Chauhan","year":"2006","unstructured":"Chauhan, A., & Chauhan, V. (2006). Oxidative stress in autism. Pathophysiology, 13, 171\u2013181. https:\/\/doi.org\/10.1016\/j.pathophys.2006.05.007","journal-title":"Pathophysiology"},{"key":"22_CR53","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.foodres.2017.07.026","volume":"100","author":"HL Schimidt","year":"2017","unstructured":"Schimidt, H. L., Garcia, A., Martins, A., Mello-Carpes, P. B., & Carpes, F. P. (2017). Green tea supplementation produces better neuroprotective effects than red and black tea in Alzheimer-like rat model. Food Research International, 100, 442\u2013448. https:\/\/doi.org\/10.1016\/j.foodres.2017.07.026","journal-title":"Food Research International"},{"key":"22_CR54","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1080\/07315724.2006.10719518","volume":"25","author":"C Cabrera","year":"2006","unstructured":"Cabrera, C., Artacho, R., & Gim\u00e9nez, R. (2006). Beneficial effects of green tea\u2014A review. Journal of the American College of Nutrition, 25, 79\u201399.","journal-title":"Journal of the American College of Nutrition"},{"key":"22_CR55","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.brainres.2011.06.063","volume":"1410","author":"D Banji","year":"2011","unstructured":"Banji, D., Banji, O. J. F., Abbagoni, S., Hayath, M. S., Kambam, S., & Chiluka, V. L. (2011). Amelioration of behavioral aberrations and oxidative markers by green tea extract in valproate induced autism in animals. Brain Research, 1410, 141\u2013151. https:\/\/doi.org\/10.1016\/j.brainres.2011.06.063","journal-title":"Brain Research"},{"key":"22_CR56","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1007\/s10571-011-9707-0","volume":"31","author":"A Takeda","year":"2011","unstructured":"Takeda, A., Sakamoto, K., Tamano, H., Fukura, K., Inui, N., Suh, S. W., et al. (2011). Facilitated neurogenesis in the developing hippocampus after intake of theanine, an amino acid in tea leaves, and object recognition memory. Cellular and Molecular Neurobiology, 31, 1079\u20131088. https:\/\/doi.org\/10.1007\/s10571-011-9707-0","journal-title":"Cellular and Molecular Neurobiology"},{"key":"22_CR57","doi-asserted-by":"crossref","unstructured":"Kumaravel, P., Melchias, G., Vasanth, N., & Manivasagam, T. (2017).\u00a0Epigallocatechin Gallate Attenuates Behavioral Defects in Sodium Valproate Induced Autism Rat Model.\u00a0Research Journal of Pharmacy and Technology, 10, 1477. https:\/\/doi.org\/10.5958\/0974-360X.2017.00260.8","DOI":"10.5958\/0974-360X.2017.00260.8"},{"key":"22_CR58","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1177\/0883073815600870","volume":"30","author":"M Sundberg","year":"2015","unstructured":"Sundberg, M., & Sahin, M. (2015). Cerebellar development and autism spectrum disorder in tuberous sclerosis complex. Journal of Child Neurology, 30, 1954\u20131962. https:\/\/doi.org\/10.1177\/0883073815600870","journal-title":"Journal of Child Neurology"},{"key":"22_CR59","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1089\/adt.2018.848","volume":"16","author":"KE Urdaneta","year":"2018","unstructured":"Urdaneta, K. E., Castillo, M. A., Montiel, N., Sempr\u00fan-Hern\u00e1ndez, N., Antonucci, N., & Siniscalco, D. (2018). Autism spectrum disorders: Potential neuro-psychopharmacotherapeutic plant-based drugs. Assay and Drug Development Technologies, 16, 433\u2013444. https:\/\/doi.org\/10.1089\/adt.2018.848","journal-title":"Assay and Drug Development Technologies"},{"key":"22_CR60","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/sj.bjp.0706040","volume":"144","author":"FN McNamara","year":"2005","unstructured":"McNamara, F. N., Randall, A., & Gunthorpe, M. J. (2005). Effects of piperine, the pungent component of black pepper, at the human vanilloid receptor (TRPV1). British Journal of Pharmacology, 144, 781\u2013790. https:\/\/doi.org\/10.1038\/sj.bjp.0706040","journal-title":"British Journal of Pharmacology"},{"key":"22_CR61","doi-asserted-by":"publisher","first-page":"3106","DOI":"10.1016\/j.fct.2008.06.014","volume":"46","author":"J Wattanathorn","year":"2008","unstructured":"Wattanathorn, J., Chonpathompikunlert, P., Muchimapura, S., Priprem, A., & Tankamnerdthai, O. (2008). Piperine, the potential functional food for mood and cognitive disorders. Food and Chemical Toxicology, 46, 3106\u20133110. https:\/\/doi.org\/10.1016\/j.fct.2008.06.014","journal-title":"Food and Chemical Toxicology"},{"key":"22_CR62","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1248\/bpb.33.598","volume":"33","author":"M Fu","year":"2010","unstructured":"Fu, M., Sun, Z.-H., & Zuo, H.-C. (2010). Neuroprotective effect of piperine on primarily cultured hippocampal neurons. Biological & Pharmaceutical Bulletin, 33, 598\u2013603.","journal-title":"Biological & Pharmaceutical Bulletin"},{"key":"22_CR63","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.bbr.2014.04.045","volume":"270","author":"B Pragnya","year":"2014","unstructured":"Pragnya, B., Kameshwari, J. S. L., & Veeresh, B. (2014). Ameliorating effect of piperine on behavioral abnormalities and oxidative markers in sodium valproate induced autism in BALB\/C mice. Behavioural Brain Research, 270, 86\u201394. https:\/\/doi.org\/10.1016\/j.bbr.2014.04.045","journal-title":"Behavioural Brain Research"},{"key":"22_CR64","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/J.CBI.2008.05.003","volume":"174","author":"T Ak","year":"2008","unstructured":"Ak, T., & G\u00fcl\u00e7in, \u0130. (2008). Antioxidant and radical scavenging properties of curcumin. Chemico-Biological Interactions, 174, 27\u201337. https:\/\/doi.org\/10.1016\/J.CBI.2008.05.003","journal-title":"Chemico-Biological Interactions"},{"key":"22_CR65","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/978-0-387-46401-5_8","volume":"595","author":"GM Cole","year":"2007","unstructured":"Cole, G. M., Teter, B., & Frautschy, S. A. (2007). Neuroprotective effects of curcumin. Advances in Experimental Medicine and Biology, 595, 197\u2013212. https:\/\/doi.org\/10.1007\/978-0-387-46401-5_8","journal-title":"Advances in Experimental Medicine and Biology"},{"key":"22_CR66","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/s12906-017-1763-7","volume":"17","author":"M Al-Askar","year":"2017","unstructured":"Al-Askar, M., Bhat, R. S., Selim, M., Al-Ayadhi, L., & El-Ansary, A. (2017). Postnatal treatment using curcumin supplements to amend the damage in VPA-induced rodent models of autism. BMC Complementary and Alternative Medicine, 17, 259. https:\/\/doi.org\/10.1186\/s12906-017-1763-7","journal-title":"BMC Complementary and Alternative Medicine"},{"key":"22_CR67","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.lfs.2015.09.012","volume":"141","author":"R Bhandari","year":"2015","unstructured":"Bhandari, R., & Kuhad, A. (2015). Neuropsychopharmacotherapeutic efficacy of curcumin in experimental paradigm of autism spectrum disorders. Life Sciences, 141, 156\u2013169. https:\/\/doi.org\/10.1016\/j.lfs.2015.09.012","journal-title":"Life Sciences"},{"key":"22_CR68","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/ptr.5211","volume":"29","author":"Y Panahi","year":"2015","unstructured":"Panahi, Y., Badeli, R., Karami, G.-R., & Sahebkar, A. (2015). Investigation of the efficacy of adjunctive therapy with bioavailability-boosted curcuminoids in major depressive disorder. Phytheraphy Research, 29, 17\u201321. https:\/\/doi.org\/10.1002\/ptr.5211","journal-title":"Phytheraphy Research"},{"key":"22_CR69","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1002\/ptr.5149","volume":"28","author":"Y Panahi","year":"2014","unstructured":"Panahi, Y., Saadat, A., Beiraghdar, F., & Sahebkar, A. (2014). Adjuvant therapy with bioavailability-boosted curcuminoids suppresses systemic inflammation and improves quality of life in patients with solid tumors: A randomized double-blind placebo-controlled trial. Phytheraphy Research, 28, 1461\u20131467. https:\/\/doi.org\/10.1002\/ptr.5149","journal-title":"Phytheraphy Research"},{"key":"22_CR70","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0031211","volume":"7","author":"S Dong","year":"2012","unstructured":"Dong, S., Zeng, Q., Mitchell, E. S., Xiu, J., Duan, Y., Li, C., et al. (2012). Curcumin enhances neurogenesis and cognition in aged rats: Implications for transcriptional interactions related to growth and synaptic plasticity. PLoS One, 7, e31211. https:\/\/doi.org\/10.1371\/journal.pone.0031211","journal-title":"PLoS One"},{"key":"22_CR71","doi-asserted-by":"publisher","first-page":"527","DOI":"10.2174\/1871527316666170413105421","volume":"16","author":"R Solimini","year":"2017","unstructured":"Solimini, R., Rotolo, M. C., Pichini, S., & Pacifici, R. (2017). Neurological disorders in medical use of cannabis: An update. CNS Neurological Disorders Drug Targets, 16, 527\u2013533. https:\/\/doi.org\/10.2174\/1871527316666170413105421","journal-title":"CNS Neurological Disorders Drug Targets"},{"key":"22_CR72","doi-asserted-by":"publisher","first-page":"2333794X1881541","DOI":"10.1177\/2333794X18815412","volume":"5","author":"CA Salgado","year":"2018","unstructured":"Salgado, C. A., & Castellanos, D. (2018). Autism spectrum disorder and cannabidiol: Have we seen this movie before? Global Pediatric Health, 5, 2333794X18815412. https:\/\/doi.org\/10.1177\/2333794X18815412","journal-title":"Global Pediatric Health"},{"key":"22_CR73","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.4155\/fmc.09.93","volume":"1","author":"P Nagarkatti","year":"2009","unstructured":"Nagarkatti, P., Pandey, R., Rieder, S. A., Hegde, V. L., & Nagarkatti, M. (2009). Cannabinoids as novel anti-inflammatory drugs. Future Medicinal Chemistry, 1, 1333\u20131349. https:\/\/doi.org\/10.4155\/fmc.09.93","journal-title":"Future Medicinal Chemistry"},{"key":"22_CR74","doi-asserted-by":"publisher","first-page":"61","DOI":"10.14581\/jer.17012","volume":"7","author":"E Perucca","year":"2017","unstructured":"Perucca, E. (2017). Cannabinoids in the treatment of epilepsy: Hard evidence at last? Journal of Epilepsy Research, 7, 61\u201376. https:\/\/doi.org\/10.14581\/jer.17012","journal-title":"Journal of Epilepsy Research"},{"key":"22_CR75","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.3390\/ijms18091916","volume":"18","author":"E Zamberletti","year":"2017","unstructured":"Zamberletti, E., Gabaglio, M., & Parolaro, D. (2017). The endocannabinoid system and autism spectrum disorders: Insights from animal models. International Journal of Molecular Sciences, 18, 1916. https:\/\/doi.org\/10.3390\/ijms18091916","journal-title":"International Journal of Molecular Sciences"},{"key":"22_CR76","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.3390\/ijms18071425","volume":"18","author":"A Brigida","year":"2017","unstructured":"Brigida, A., Schultz, S., Cascone, M., Antonucci, N., & Siniscalco, D. (2017). Endocannabinoid signal dysregulation in autism spectrum disorders: A correlation link between inflammatory state and neuro-immune alterations. International Journal of Molecular Sciences, 18, 1425. https:\/\/doi.org\/10.3390\/ijms18071425","journal-title":"International Journal of Molecular Sciences"},{"key":"22_CR77","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1024\/1422-4917\/a000309","volume":"42","author":"H Uebel-von Sandersleben","year":"2014","unstructured":"Uebel-von Sandersleben, H., Rothenberger, A., Albrecht, B., Rothenberger, L. G., Klement, S., & Bock, N. (2014). Ginkgo biloba extract EGb 761 \u00ae in children with ADHD. Zeitschrift f\u00fcr Kinder- und Jugendpsychiatrie und Psychotherapie, 42, 337\u2013347. https:\/\/doi.org\/10.1024\/1422-4917\/a000309","journal-title":"Zeitschrift f\u00fcr Kinder- und Jugendpsychiatrie und Psychotherapie"},{"key":"22_CR78","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s40262-013-0074-5","volume":"52","author":"C Ude","year":"2013","unstructured":"Ude, C., Schubert-Zsilavecz, M., & Wurglics, M. (2013). Ginkgo biloba extracts: A review of the pharmacokinetics of the active ingredients. Clinical Pharmacokinetics, 52, 727\u2013749. https:\/\/doi.org\/10.1007\/s40262-013-0074-5","journal-title":"Clinical Pharmacokinetics"},{"key":"22_CR79","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ejps.2009.10.002","volume":"39","author":"W Fang","year":"2010","unstructured":"Fang, W., Deng, Y., Li, Y., Shang, E., Fang, F., Lv, P., et al. (2010). Blood brain barrier permeability and therapeutic time window of Ginkgolide B in ischemia\u2013reperfusion injury. European Journal of Pharmaceutical Sciences, 39, 8\u201314. https:\/\/doi.org\/10.1016\/j.ejps.2009.10.002","journal-title":"European Journal of Pharmaceutical Sciences"},{"key":"22_CR80","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1002\/ptr.2778","volume":"23","author":"H Niederhofer","year":"2009","unstructured":"Niederhofer, H. (2009). First preliminary results of an observation of Ginkgo Biloba treating patients with autistic disorder. Phytheraphy Research, 23, 1645\u20131646. https:\/\/doi.org\/10.1002\/ptr.2778","journal-title":"Phytheraphy Research"},{"key":"22_CR81","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1007\/s10578-012-0292-3","volume":"43","author":"E Hasanzadeh","year":"2012","unstructured":"Hasanzadeh, E., Mohammadi, M.-R., Ghanizadeh, A., Rezazadeh, S.-A., Tabrizi, M., Rezaei, F., et al. (2012). A double-blind placebo controlled trial of ginkgo biloba added to risperidone in patients with autistic disorders. Child Psychiatry and Human Development, 43, 674\u2013682. https:\/\/doi.org\/10.1007\/s10578-012-0292-3","journal-title":"Child Psychiatry and Human Development"}],"container-title":["Advances in Neurobiology","Personalized Food Intervention and Therapy for Autism Spectrum Disorder Management"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-30402-7_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T02:32:55Z","timestamp":1614220375000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-030-30402-7_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9783030304010","9783030304027"],"references-count":81,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-30402-7_22","relation":{},"ISSN":["2190-5215","2190-5223"],"issn-type":[{"value":"2190-5215","type":"print"},{"value":"2190-5223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"1 February 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}